Weekly shot helps people shed pounds in Year-Long study
NCT ID NCT06041217
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tested a weekly injection of semaglutide (2.4 mg) to help adults with overweight or obesity lose weight. About 242 people took part, comparing the drug to a placebo over roughly one year. The main goal was to see how much weight they lost and how many lost at least 5% of their body weight.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for OBESITY are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Beijing Hospital
Beijing, Beijing Municipality, 100730, China
-
Changzhou No.2 People's Hospital, Yanghu Branch
Changzhou, Jiangsu, 213003, China
-
China Medical University Hospital
Taichung, 404, Taiwan
-
Chongqing University Three Gorges Hospital
Chongqing, Chongqing Municipality, 404000, China
-
Ditmanson Medical Foundation Chia-Yi Christian Hospital
Chiayi City, 600, Taiwan
-
Fujian Medical University Union Hospital-Endocrinology
Fuzhou, Fujian, 350001, China
-
Hengshui People's Hospital (Harrison International Peace Hospital)-Endocrinology
Hengshui, Hebei, 053000, China
-
Huizhou Central People's Hospital-Endocrinology
Huizhou, Guangdong, 516001, China
-
Jinan Central Hospital
Jinan, Shandong, 250013, China
-
National Cheng Kung University Hospital
Tainan, 704, Taiwan
-
National Taiwan University Hospital_main
Taipei, 100, Taiwan
-
Qinghai Provincial People's Hospital
Xining, Qinghai, 810007, China
-
Shanghai Fifth People's Hospital-Endocrinology
Shanghai, Shanghai Municipality, 200240, China
-
Shanghai Pudong New Area People's Hospital-Endocrinology
Shanghai, Shanghai Municipality, 201200, China
-
Shiyan Taihe Hospital (Affiliated Hospital of Hubei University of Medicine)-Endocrinology
Shiyan, Hubei, 442008, China
-
Taipei Medical University Hospital
Taipei, 110, Taiwan
-
The Affiliated Hospital of Jiangsu University-Endocrinology
Zhenjiang, Jiangsu, 212001, China
-
The First Bethune hospital of Jilin University-Endocrinology
Changchun, Jilin, 130061, China
-
The Second Affiliated Hospital of Nanjing Medical University-Endocrinology
Nanjing, Jiangsu, 210011, China
-
The Second Affiliated Hospital of Nanjing Medical University_Nanjing
Nanjing, Jiangsu, 210011, China
-
Tongren Hospital Shanghai Jiao Tong University School of Medicine
Shanghai, Shanghai Municipality, 200336, China
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Daily pill could offer new hope for weight loss in east asian adults
- Can a new stomach and gut bypass surgery tackle obesity and diabetes?
- Can a Two-Drug combo tip the scales against obesity?
- Can Weight-Loss surgery change how medications work?
- Coffee grounds probiotic could reshape gut health and fight inflammation
- Can shedding pounds reboot the Heart's exercise engine?